-Projects & data isolated and unorganized
-No central library of validated methods
-Subject Matter Experts few and isolated
-Human-relevant tools widely unknown
-Volume of data required out of reach
-Cutting-edge technologies languishing
-Validation parameters confusing
-21st century IT capabilities untapped
-Observational to predictive model skewed
-Drug discovery resource-intensive
-Opportunities for collaboration efforted
-Slow pace of onboarding knowledge
-Industry is in economic stall
-Projects and data organized & accessible
-Library of validated methods: existing & new
-Subject Matter socialized for participation
-Human relevant tools mainstreamed
-Big Data enabled & plentiful
-Innovation spurred
-Validation parameters straight-forward
-Alignment with today's Big Data
-Logical path to predictive model unfolds
-Process streamlined/economical
-Easy flow of collaboration
-Structure supports education
-Economic boon with catapult to 21st century
Copyright © 2018 GIVVISH - All Rights Reserved.
Powered by GoDaddy